2-Bromo-5-nitrophenol, 95.0%, 5g

cis-3,3,5-Trimethylcyclohexanol (contains ca. 20% trans- isomer)>80.0%(GC)25g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid, 95.0%, 100mg

(R)-1-(2-(trifluoromethyl)phenyl)ethanol, 95%, 100mg

Diphenyl(p-tolyl)methanol, 95.0%, 5g

Tert-butyln-[(1s)-1-(4-bromophenyl)-2-hydroxy-ethyl]carbamate, 98%, 500mg

N-(5-Chloropyrimidin-2-yl)acetamide, 95%, 100mg

Acetic acid isobutyl ester, min. 99%, for synthesis, 2.5 l, glass packaging

4,4,5,5-Tetramethyl-2-(4-((3-(trifluoromethyl)benzyl)oxy)phenyl)-1,3,2-dioxaborolane, 98%, 250mg

4-(2-Fluoropyridin-4-yl)-2-(methylthio)pyrimidine, 95%, 5g

[3-(3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]amine, 95.0%, 500mg

5-Bromo-4-chloro-2-methylpyridine, 95.0%, 2.5g

tert-Butyl 5-methyl-2,4-dioxopiperidine-1-carboxylate, 95.0%, 1g